Chlorpromazine Hydrochloride NDC 71656-101

NDC codes

FDA NDC Directory

Product NDC (as listed)71656-101Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71656-0101Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71656-101-08	71656010108	240 mL in 1 BOTTLE, PLASTIC (71656-101-08)Marketed from Mar 4, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Chlorpromazine Hydrochloride
Generic name (nonproprietary): chlorpromazine hydrochloride
Active ingredients: Chlorpromazine hydrochloride — 100 mg/mL
Dosage form: Concentrate
Route: Oral
Labeler: Saptalis Pharmaceuticals, LLC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 080983
Marketing start: Mar 4, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Phenothiazines (Chemical structure)
Identifiers: Product ID 71656-101_4bd1c301-1f67-287b-e063-6294a90ae138SPL ID 4bd1c301-1f67-287b-e063-6294a90ae138SPL set ID cd8f9e23-d08a-4d96-8fe9-35ab2bc861c8RxCUI 991053, 991332UNII 9WP59609J6
Pharmacologic class: Phenothiazine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471656010108 followed by a unit qualifier and the quantity

Package 71656-0101-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 27, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the treatment of tetanus. To control the manifestations of the manic type of manic-depressive illness. For relief of intractable hiccups. For the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanyi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 080983

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 080983
Product	Strength	Form · route	Labeler	Product NDC
Chlorpromazine Hydrochloride	Chlorpromazine hydrochloride 30 mg/mL	ConcentrateOral	Saptalis Pharmaceuticals, LLC.	71656-102